Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.5M |
 |
Gilead SciencesGILD |
-$4.04B |
 |
AmgenAMGN |
-$189M |
 |
Editas MedicineEDIT |
-$7M |
 |
Crispr TherapeuticsCRSP |
-$171M |
Are Royalty Pharma Insiders Buying or Selling?
Royalty Pharma (RPRX) has had 6 insider transactions in the past 90 days, all sells. The most recent was Marshall Urist, who sold 4,126 shares at $57.10 on October 5, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the RPRX AI Score. For government officials trading this stock, see RPRX congressional trading.
Who’s Trading Royalty Pharma Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| Terrance Coyne | Sold $39M | 35 | Aug 13, 2026 |
| Christopher Hite | Sold $27M | 9 | Sep 22, 2026 |
| George Lloyd | Sold $14M | 11 | Dec 18, 2025 |
| Marshall Urist | Sold $12M | 17 | Oct 5, 2026 |
| Gregory Norden | Sold $1.4M | 2 | May 14, 2026 |
Recent Royalty Pharma Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Marshall Urist | Oct 5, 2026 | Sell | 4,126 | $57.1 | $240,000 |
| Christopher Hite | Sep 22, 2026 | Sell | 96,073 | $58.51 | $5.6M |
| Christopher Hite | Sep 22, 2026 | Sell | 3,927 | $58.93 | $230,000 |
| Christopher Hite | Aug 18, 2026 | Sell | 100,000 | $59.97 | $6M |
| Terrance Coyne | Aug 13, 2026 | Sell | 9,230 | $58.59 | $540,000 |
| Terrance Coyne | Aug 13, 2026 | Sell | 1,772 | $59.14 | $100,000 |
| Marshall Urist | Jul 1, 2026 | Sell | 9,099 | $55.88 | $510,000 |
| Christopher Hite | Jun 30, 2026 | Sell | 97,446 | $56.5 | $5.5M |
| Christopher Hite | Jun 30, 2026 | Sell | 29,400 | $56.44 | $1.7M |
| Christopher Hite | Jun 30, 2026 | Sell | 2,554 | $57.1 | $150,000 |
| Christopher Hite | Jun 30, 2026 | Sell | 600 | $57.09 | $34,000 |
| Marshall Urist | Jun 24, 2026 | Sell | 9,098 | $55.18 | $500,000 |
| Christopher Hite | Jun 23, 2026 | Sell | 117,592 | $54.47 | $6.4M |
| Christopher Hite | Jun 23, 2026 | Sell | 32,408 | $54.11 | $1.8M |
| Terrance Coyne | May 26, 2026 | Sell | 64,399 | $53.98 | $3.5M |
| Marshall Urist | May 20, 2026 | Sell | 13,684 | $52.75 | $720,000 |
| Marshall Urist | May 14, 2026 | Sell | 13,684 | $53.06 | $730,000 |
| Gregory Norden | May 14, 2026 | Sell | 3,045 | $53 | $160,000 |
| Terrance Coyne | Apr 28, 2026 | Sell | 32,916 | $49.78 | $1.6M |
| Terrance Coyne | Apr 28, 2026 | Sell | 1,875 | $49.78 | $93,000 |
| Terrance Coyne | Apr 1, 2026 | Sell | 32,916 | $48.33 | $1.6M |
| Terrance Coyne | Apr 1, 2026 | Sell | 1,875 | $48.33 | $91,000 |
| Terrance Coyne | Mar 23, 2026 | Sell | 32,916 | $45.53 | $1.5M |
| Terrance Coyne | Mar 23, 2026 | Sell | 1,875 | $45.53 | $85,000 |
| Terrance Coyne | Mar 2, 2026 | Sell | 22,487 | $46.67 | $1M |
| Terrance Coyne | Mar 2, 2026 | Sell | 10,429 | $47.01 | $490,000 |
| Terrance Coyne | Mar 2, 2026 | Sell | 1,292 | $46.67 | $60,000 |
| Terrance Coyne | Mar 2, 2026 | Sell | 583 | $47.01 | $27,000 |
| Terrance Coyne | Feb 23, 2026 | Sell | 32,916 | $45.32 | $1.5M |
| Terrance Coyne | Feb 23, 2026 | Sell | 1,875 | $45.32 | $85,000 |
| Terrance Coyne | Feb 4, 2026 | Sell | 19,076 | $43.29 | $830,000 |
| Terrance Coyne | Feb 4, 2026 | Sell | 1,087 | $43.29 | $47,000 |
| Terrance Coyne | Feb 3, 2026 | Sell | 108,759 | $42.84 | $4.7M |
| Terrance Coyne | Feb 3, 2026 | Sell | 6,195 | $42.84 | $270,000 |
| Terrance Coyne | Feb 2, 2026 | Sell | 102,581 | $42.08 | $4.3M |
| Terrance Coyne | Feb 2, 2026 | Sell | 5,843 | $42.08 | $250,000 |
| Marshall Urist | Jan 30, 2026 | Sell | 20,000 | $41.09 | $820,000 |
| Marshall Urist | Jan 23, 2026 | Sell | 20,000 | $40.26 | $810,000 |
| Terrance Coyne | Jan 20, 2026 | Sell | 65,832 | $39.35 | $2.6M |
| Terrance Coyne | Jan 20, 2026 | Sell | 3,750 | $39.35 | $150,000 |
| Marshall Urist | Jan 16, 2026 | Sell | 20,000 | $39.52 | $790,000 |
| Marshall Urist | Jan 9, 2026 | Sell | 20,000 | $40.78 | $820,000 |
| Marshall Urist | Jan 2, 2026 | Sell | 20,000 | $38.48 | $770,000 |
| Terrance Coyne | Jan 2, 2026 | Sell | 65,832 | $38.42 | $2.5M |
| Terrance Coyne | Jan 2, 2026 | Sell | 3,750 | $38.42 | $140,000 |
| Marshall Urist | Dec 26, 2025 | Sell | 20,000 | $39.32 | $790,000 |
| Marshall Urist | Dec 19, 2025 | Sell | 20,000 | $38.38 | $770,000 |
| George Lloyd | Dec 18, 2025 | Sell | 30,654 | $38.5 | $1.2M |
| George Lloyd | Dec 17, 2025 | Sell | 79,346 | $38.57 | $3.1M |
| Marshall Urist | Dec 16, 2025 | Sell | 20,000 | $38.32 | $770,000 |
| Terrance Coyne | Dec 15, 2025 | Sell | 65,832 | $38.36 | $2.5M |
| Terrance Coyne | Dec 15, 2025 | Sell | 3,750 | $38.36 | $140,000 |
| Marshall Urist | Dec 5, 2025 | Sell | 23,334 | $39.15 | $910,000 |
| Marshall Urist | Dec 5, 2025 | Sell | 18,242 | $39.15 | $710,000 |
| George Lloyd | Dec 3, 2025 | Sell | 110,000 | $39.77 | $4.4M |
| Marshall Urist | Dec 1, 2025 | Sell | 23,333 | $39.93 | $930,000 |
| Marshall Urist | Dec 1, 2025 | Sell | 18,242 | $39.9 | $730,000 |
| Terrance Coyne | Dec 1, 2025 | Sell | 65,832 | $39.87 | $2.6M |
| Terrance Coyne | Dec 1, 2025 | Sell | 3,750 | $39.87 | $150,000 |
| Terrance Coyne | Nov 24, 2025 | Sell | 55,146 | $38.67 | $2.1M |
| Terrance Coyne | Nov 24, 2025 | Sell | 10,686 | $37.96 | $410,000 |
| Terrance Coyne | Nov 24, 2025 | Sell | 3,126 | $38.67 | $120,000 |
| Terrance Coyne | Nov 24, 2025 | Sell | 624 | $37.96 | $24,000 |
| George Lloyd | Nov 19, 2025 | Sell | 47,798 | $38.28 | $1.8M |
| George Lloyd | Nov 19, 2025 | Sell | 47,401 | $38.28 | $1.8M |
| George Lloyd | Nov 19, 2025 | Sell | 25,530 | $38.28 | $980,000 |
| George Lloyd | Nov 19, 2025 | Sell | 4,628 | $39.01 | $180,000 |
| George Lloyd | Nov 19, 2025 | Sell | 4,599 | $39.01 | $180,000 |
| George Lloyd | Nov 19, 2025 | Sell | 2,770 | $38.29 | $110,000 |
| George Lloyd | Nov 19, 2025 | Sell | 2,470 | $39.01 | $96,000 |
| George Lloyd | Nov 19, 2025 | Sell | 230 | $39.03 | $9,000 |
| Terrance Coyne | Nov 17, 2025 | Sell | 65,844 | $39.3 | $2.6M |
| Terrance Coyne | Nov 17, 2025 | Sell | 3,750 | $39.3 | $150,000 |
| Gregory Norden | Aug 11, 2025 | Sell | 33,500 | $36.23 | $1.2M |
Frequently Asked Questions: Royalty Pharma Insider Trading
In the past 90 days, Royalty Pharma insiders have made 0 buys and 6 sells. The net selling may indicate insiders are taking profits or reducing exposure.
The most recent sale was by Marshall Urist who sold 4,126 shares on October 5, 2026. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
Coyne Terrance P. has sold the most RPRX stock in the last 2 years, with a total value of $39M.
The total value of insider transactions for Royalty Pharma in the last 2 years is negative, amounting to -$94M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
